SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: Cybersecurity, Internet of Things (IoT), and Licensing and Other. The Cybersecurity segment includes the brand Cylance, BlackBerry Spark, AtHoc, and SecuSUITE. The IoT segment focuses on software licenses, support, maintenance, and professional services. The Licensing and Other segment involves the intellectual property licensing arrangements and settlement awards. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is trending as the community discusses its potential driven by partnerships and its QNX technology, particularly within the automotive sector. Some investors are focused on technical indicators, while others highlight the importance of upcoming earnings and news related to new deals, including expansion in Asia. There is a sense of anticipation for a breakout, with community members expressing strong conviction in the company's long-term prospects.

Ucore Rare Metals, Inc. Is a technology company, which engages in the business of metal separation products, and services to the mining and mineral extraction industry. Its projects include Bokan-Dotson Ridge Rare Earth Element. The company was founded on October 5, 2006 and is headquartered in Halifax, Canada.

Ucore Rare Metals Inc

Ucore Rare Metals Inc.

Ucore Rare Metals is trending amid speculation of upcoming deals with the Canadian government, potentially mirroring recent offtake agreements in the critical minerals sector. Community members are excited about Ucore's refining capabilities and its role in establishing North American supply chain independence, especially with the G7 summit underway. Trading halts and price volatility reflect both anticipation and nervousness as investors await news.

FuelCell Energy, Inc. engages in the business of developing, designing, producing, constructing, and servicing high temperature fuel cells for clean electric power generation. It operates through the following geographical segments: the United States, South Korea, and Europe. The company was founded by Bernard Baker and Martin G. Klein in 1969 and is headquartered in Danbury, CT.

Fuelcell Energy Inc

FuelCell Energy is trending as investors draw comparisons to Bloom Energy's recent gains, speculating that FCEL could follow a similar trajectory. The community is actively discussing potential partnerships and contracts, particularly in the context of increasing demand for AI data centers and growing interest in the company's carbon capture technology with ExxonMobil. Some investors are speculating that a deal related to AI data centers could cause a price surge.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

AUPH is trending amid discussions of a recent sharp decline apparently triggered by comments from an FDA official, raising concerns about market manipulation and potential conflicts of interest. While the official retracted the statement, the stock has struggled to recover, leading to frustration among investors and calls for a stronger response from the company's leadership. The community speculates on potential buyback programs, upcoming earnings, and the possibility of a buyout to restore investor confidence.

Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.

Galectin Therapeutics Inc

GALT is trending as investors anticipate upcoming presentations at the AASLD Liver Meeting in November, with the community closely watching for potential partnership or buyout news before year-end. Discussions center on the value of Belapectin, especially in combination with GLP-1 drugs, and the possibility of a short squeeze given the high short interest. Community members are actively debating potential buyout prices and the impact of upcoming presentations on the stock's valuation.

"Shina Inu is a decentralized meme token on the Ethereum blockchain. Its mission is to give back to the crypto community, give to charity, and win the heart of the greatest token of all time, Shiba Inu!   Shina Token is a very fun meme token project that has sold many rare and beautiful NFTs. NFT sales are used to support the team and provide upcoming features such as exclusive access to events and rewards that will soon be announced."

Shina Inu

Shina Inu is gaining attention as community members point to strong accumulation patterns and increasing bullish sentiment. Discussions highlight the potential for a significant move as market participants quietly position themselves. The focus remains on the underlying strength and the anticipation of a coming breakout.

Mannatech, Inc. engages in the development of nutritional supplements, topical and skin care products and weight-management products that target optimal health and wellness. Its product category includes integrative health, targeted health, wealth and fitness, skin care, essentials, and home. The company was founded by Marlin Ray Robbins and Samuel L. Caster in November 1993 and is headquartered in Flower Mound, TX.

Mannatech Inc

MTEX is trending due to its low float, leading to discussions of potential squeezes and comparisons to other high-momentum stocks like HKD and CURR. The community is actively watching for breakouts, particularly above the $15 mark, with some anticipating a run towards $20. Recent trading patterns and potential for high percentage gains are also fueling the interest.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

META is trending as investors grapple with the implications of increased AI spending and a one-time tax charge impacting earnings, leading to community debates on whether the dip is a buying opportunity or a sign of deeper concerns. Community members are actively discussing potential support levels, options activity, and whether the stock is oversold, while others express frustration with the stock's recent performance. Despite the concerns, some bulls remain confident in META's long-term potential and ability to monetize its massive user base.

Lumen Technologies, Inc. is an investment holding company, which engages in the provision of integrated communications to residential and business customers. It operates through the Business and Mass Markets segments. The Business segment provides products and services under four sales channels to enterprise and commercial customers. The Mass Markets segment focuses on consumer and small business customers. The company was founded in 1930 and is headquartered in Monroe, LA.

Lumen Technologies Inc

LUMN is trending as investors rally behind the company's AI-driven turnaround story following a narrowed Q3 loss and new AI-driven connectivity deals. The community is actively discussing the potential for a significant bounce, with some anticipating a short squeeze and a run to higher price levels. Bullish sentiment is fueled by the improving outlook and strategic partnerships, positioning LUMN as a key player in the AI infrastructure space.

NewcelX Ltd.

NCEL is trending due to the completion of its merger with Kadimastem, alongside a planned reverse split and ticker change, generating both excitement and confusion. Community members are actively discussing the mechanics of the merger, reverse split, and potential short squeeze scenarios. Traders are also debating appropriate valuations and entry/exit points amidst the volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$AMRSQ One of the most precarious phases of large-scale fermentation is the biomass accumulation phase. This is when yeast are allowed to multiply to reach a high density of cells ready to commence synthesis. During this phase, some cells will develop mutations that allow them to escape synthesis, creating a fitness advantage. This advantage allows them to propagate more quickly than the other cells, overwhelming the population with mutant yeast cells that will not be productive (thereby destroying yield). 

The recent patent filing below reveals Amyris scientists found that if they introduced an “on/off switch”, which would suppress production until the switch is flipped, the strains were considerably more stable. One “switch” is oxygen sensitive, so that when a controlled amount of oxygen is introduced (micro aerobic conditions), synthesis will start. The other “switch” is the simple sugar maltose, which can be added after the accumulation phase is complete. 

https://patentscope.wipo.int/search/en/detail.jsf?docId=US304654671&amp;tab=PCTDESCRIPTION&amp;_cid=P20-KFBS1U-58832-1

Tom Cross

GreenAndGreen

HulkSmash

K Fujii

D Cup

AaronGLow

Rodger Rodger

EpicurusFan

KnysnaNow

Nukie

auntmarie

SomewhatMemorable

John

Fant Winter

Investor

N808

recentlyChanged

Kelly Woods

fernando

Optionsna1st

Peter

BearGuru

Salesmaster99

Yoda

Ken Holmes

Onfish2000

Ian Asgard

The present disclosure relates to the use of a switch for the production of heterologous non-catabolic compounds in microbial host cells. In one aspect, provided herein are genetically modified microorganisms that produce non-catabolic compounds more stably when serially cultured under aerobic conditions followed by microaerobic conditions, and methods of producing non-catabolic compounds by culturing the genetically modified microbes under such culture conditions.

Wipo

US20200270643 METHODS FOR STABILIZING PRODUCTION OF ACETYL-COENZYME A DERIVED COMPOUNDS

StockTwits for iOS

Amyris Inc

$AMRS One of the most precarious phases of large-scale fermentation is the biomass accumulation phase. This is when yeast are allowed to multiply to reach a high density of cells ready to commence synthesis. During this phase, some cells will develop mutations that allow them to escape synthesis, creating a fitness advantage. This advantage allows them to propagate more quickly than the other cells, overwhelming the population with mutant yeast cells that will not be productive (thereby destroying yield). 

The recent patent filing below reveals Amyris scientists found that if they introduced an “on/off switch”, which would suppress production until the switch is flipped, the strains were considerably more stable. One “switch” is oxygen sensitive, so that when a controlled amount of oxygen is introduced (micro aerobic conditions), synthesis will start. The other “switch” is the simple sugar maltose, which can be added after the accumulation phase is complete. 



Wiffle1

@Wiffle1 

In your estimate, what are the implications of this advancement? Do you think it creates a moat that other synthbio firms will have to contend with? Or is this merely a natural progression that all leading synthbio firms will have to go through at some point?

StockTwits Web

 

In your estimate, what are the implications of this advancement? Do you think it creates a moat that other synthbio firms will have to contend with? Or is this merely a natural progression that all leading synthbio firms will have to go through at some point?

@GreenAndGreen Great question. Anyone using organisms for synthesis from bacteria to yeast to mammalian cell lines uses a simple switch to control synthesis. The problem is that those simple switches are often “leaky”, which means you get some synthesis when you don’t want it - and that is where the mutational problems arise. 

What differentiates this patent is that they have tied synthesis to an additional on/off switch (on top of the standard/pre-existing one) dependent on oxygen, allowing for much tighter regulation and control. I’m not an expert in yeast, but this approach is pretty creative/novel, and their data suggests it has real implications for strain stability. The best part is that this approach can be applied to any industrial fermentation process, so it could affect their whole pipeline. So to answer your question, their moat is absolutely getting wider.

Ben M

T_Woo

Firegamerx

 Great question. Anyone using organisms for synthesis from bacteria to yeast to mammalian cell lines uses a simple switch to control synthesis. The problem is that those simple switches are often “leaky”, which means you get some synthesis when you don’t want it - and that is where the mutational problems arise. 

What differentiates this patent is that they have tied synthesis to an additional on/off switch (on top of the standard/pre-existing one) dependent on oxygen, allowing for much tighter regulation and control. I’m not an expert in yeast, but this approach is pretty creative/novel, and their data suggests it has real implications for strain stability. The best part is that this approach can be applied to any industrial fermentation process, so it could affect their whole pipeline. So to answer your question, their moat is absolutely getting wider.

@Wiffle1 thanks for the education. Really appreciate it.

 thanks for the education. Really appreciate it.

@Wiffle1 SIMPLY SUPERIOR, AND MOST USEFUL POST.  Thanks most kindly @Wiffle1

 SIMPLY SUPERIOR, AND MOST USEFUL POST.  Thanks most kindly 

@Wiffle1 No production manager wants to deal with this or dual end products (farnesene + carotenoids). Pie-in-the-sky.